Financing
Financing Cash Flow
Gilead Sciences Financing Cash Flow increased by 15.2% to -$1.26B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Financing Cash Flow shows an upward trend with a -4.4% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
Metric ID:
cf_net_cash_from_financingHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$931.00M | -$3.53B | -$1.94B | -$1.79B | -$1.00B | -$2.12B | -$1.55B | -$1.41B | -$1.10B | -$1.52B | -$1.10B | -$1.36B | -$2.95B | -$1.38B | -$3.43B | -$1.57B | -$1.49B | -$1.26B |
| QoQ Change | — | -278.8% | +44.9% | +7.6% | +44.1% | -111.2% | +26.6% | +9.5% | +21.7% | -38.0% | +27.6% | -23.8% | -117.0% | +53.3% | -148.4% | +54.3% | +5.0% | +15.2% |
| YoY Change | — | — | — | — | -7.7% | +39.9% | +20.0% | +21.6% | -9.8% | +28.3% | +29.3% | +3.2% | -168.2% | +9.2% | -151.7% | +46.9% | -8.0% | — |
Range-$3.53B – -$931.00M
CAGR+7.4%
Avg YoY Growth-11.3%
Median YoY Growth+9.2%
Current Streak3 quarters growth
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's financing cash flow?
- Gilead Sciences (GILD) reported financing cash flow of -$1.26B in Q4 2025.
- What is the long-term trend for Gilead Sciences's financing cash flow?
- Over 3 years (2021 to 2025), Gilead Sciences's financing cash flow has grown at a -4.4% compound annual growth rate (CAGR), from -$8.88B to -$7.75B.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.